CN101942039B - Parnaparin production method - Google Patents

Parnaparin production method Download PDF

Info

Publication number
CN101942039B
CN101942039B CN2010102871329A CN201010287132A CN101942039B CN 101942039 B CN101942039 B CN 101942039B CN 2010102871329 A CN2010102871329 A CN 2010102871329A CN 201010287132 A CN201010287132 A CN 201010287132A CN 101942039 B CN101942039 B CN 101942039B
Authority
CN
China
Prior art keywords
concentration
adjust
dissolved
heparin
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2010102871329A
Other languages
Chinese (zh)
Other versions
CN101942039A (en
Inventor
郭林
李�荣
崔慧斐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DONGYING TIANDONG PHARMACEUTICAL CO LTD
Shandong Haike Chemical Co ltd
Original Assignee
DONGYING TIANDONG PHARMACEUTICAL Co Ltd
SHANDONG HI-TECH CHEMICAL GROUP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DONGYING TIANDONG PHARMACEUTICAL Co Ltd, SHANDONG HI-TECH CHEMICAL GROUP Co Ltd filed Critical DONGYING TIANDONG PHARMACEUTICAL Co Ltd
Priority to CN2010102871329A priority Critical patent/CN101942039B/en
Publication of CN101942039A publication Critical patent/CN101942039A/en
Application granted granted Critical
Publication of CN101942039B publication Critical patent/CN101942039B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a preparation method of a biochemical medicament, in particular to a parnaparin production method. The invention adopts a technical scheme that the parnaparin production method comprises the following steps: adding sodium acetate and sodium chloride to a heparin sodium solution the concentration of which is 2-3%, adjusting the pH value to 7-8, respectively adding dissolved Cu<2+>, adding hydrogen peroxide the concentration of which is 2-3%, and keeping in a water bath at 50-55 DEG C to be subject to a degradation reaction; and removing heavy metal, decolorizing and freeze-drying to obtain the parnaparin product. The method has the advantage of simple operation and can realize industrial production. In the presence of Cu<2+>, the heparin reacts with the peroxide under alkaline conditions to degrade. However, the degradation reaction is quite random, glycosidic bonds among uronic acids or glucosamines has the possibility of being broken, and the obtained product is composed of multiple sugar chains.

Description

A kind of handkerchief heparin working method
One, technical field:
The present invention relates to a kind of preparation method of biochemical drug, particularly a kind of handkerchief heparin working method.
Two, background technology:
The handkerchief heparin is a kind of anti-freezing and antithrombotic reagent, is a kind of of Low molecular heparin, and the anti-blood with quick and lasting long-acting is fastened agent, has minimum hemorrhage risk simultaneously.The handkerchief heparin is a kind of Low molecular heparin that separates, purifies and obtained through the chemical process of patent registration, and common way is under the katalysis of cupric ion, forms through the hydrogen peroxide degradation heparin.Domestic still do not have this a kind products production that meets the European Pharmacopoeia requirement, and USP is not included this product.
Three, summary of the invention:
The object of the invention is exactly the above-mentioned defective that exists to prior art, and a kind of handkerchief heparin working method is provided, and has confirmed the top condition of hydrogen peroxide degradation, and the purifying process of handkerchief heparin has been proposed clear and definite method.The product of producing with this law is fit to suitability for industrialized production, and constant product quality.
The present invention adopts following technical scheme to realize: taking heparin sodium adds purified water and is dissolved into 2%~3% concentration; Add sodium acetate and sodium-chlor; Adjust pH to 7~8, venus crystals that the adding dissolving is good respectively and volume ratio are 2%~3% hydrogen peroxide; Put and begin reaction in 50~55 ℃ of water-baths, during control pH value and temperature; Behind the DeR 18-24h, adjust pH=9.5~10.0 add EDTA.2Na, react after 4 hours, transfer pH neutral, and 3 times of amount ethanol sedimentations are placed 21h; The gained throw out is dissolved into 10%~15% concentration, handles through strong acidic ion resin, collect effluent, and adjust pH accomplishes through plastic resin treatment to neutral, effluent adds the medicinal alcohol deposition of 3 times of amounts, places 5h; The gained throw out is dissolved into 10%~15% concentration, and adjust pH=9.5~10.0 add volume ratio and are 0.5% hydrogen peroxide oxidation 6-12h; The adding volume ratio is 1% sodium-chlor, membrane filtration, and the filtrating adjust pH is to neutral; 3 times of amount medicinal alcohol depositions are placed 6-12h; The gained throw out is dissolved into 10%~15% concentration, and lyophilize or throw out be through ethanol dehydration, dry handkerchief heparin finished product.
The invention has the beneficial effects as follows: confirmed the technical process of suitability for industrialized production, proposed the purification process that a cover is optimized, product stability is good, and yield is high.The product that this technology is produced meets the European Pharmacopoeia requirement, compares the anti-blood with quick and lasting long-acting with conventional heparin and fastens agent, has minimum hemorrhage risk simultaneously and can fill up the blank that domestic nothing meets the products production that European Pharmacopoeia requires.
Four, description of drawings:
Accompanying drawing 1 is a schematic flow sheet of the present invention.
Five, embodiment:
In conjunction with accompanying drawing 1, the present invention is done further description:
Taking heparin sodium, purified water are dissolved into 2%~3% concentration, add sodium acetate, sodium-chlor; Transfer pH7~8, the good venus crystals of adding dissolving adds 2%~3% hydrogen peroxide (v/v volume ratio, down together) respectively; Put in 50~55 ℃ of water-baths, begin the reaction, during control pH, temperature.Behind DeR 18~24h, transfer PH=9.5~10.0, add EDTA.2Na (EDTA Disodium), react after 4 hours, transfer pH neutral, 3 times of amount ethanol sedimentations are placed 21h.The gained throw out is dissolved into 10%~15% concentration, through strong acidic ion resin, handles like the 001X7 resin bed, collect effluent, and transfer pH neutral, accomplish through plastic resin treatment, effluent adds the medicinal alcohol deposition of 3 times of amounts, places 5h.The gained throw out is dissolved into 10%~15% concentration, transfers pH=9.5~10.0, add 0.5% hydrogen peroxide oxidation; Oxidation 6~12h adds 1%NaCl (v/v volume ratio), 0.65 μ m membrane filtration; Filtrating transfers pH neutral, and 3 times of amount medicinal alcohol depositions are placed 6~12h.The gained throw out is dissolved into 10%~15% concentration, lyophilize or throw out through ethanol dehydration in below 50 ℃, dry handkerchief heparin finished product below the vacuum tightness 0.095Mpa.

Claims (1)

1. handkerchief heparin working method, it is characterized in that being processed by following technology: taking heparin sodium adds purified water and is dissolved into 2%~3% concentration, adds sodium acetate and sodium-chlor; Adjust pH to 7~8; Venus crystals that the adding dissolving is good respectively and volume ratio are 2%~3% hydrogen peroxide, put in 50~55 ℃ of water-baths; Begin reaction, during control pH value and temperature; Behind the DeR 18-24h, adjust pH=9.5~10.0 add EDTA Disodium, react after 4 hours, transfer pH neutral, and 3 times of amount ethanol sedimentations are placed 21h; The gained throw out is dissolved into 10%~15% concentration, handles through strong acidic ion resin, collect effluent, and adjust pH accomplishes through plastic resin treatment to neutral, effluent adds the medicinal alcohol deposition of 3 times of amounts, places 5h; The gained throw out is dissolved into 10%~15% concentration, and adjust pH=9.5~10.0 add volume ratio and are 0.5% hydrogen peroxide oxidation 6-12h; The adding volume ratio is 1% sodium-chlor, membrane filtration, and the filtrating adjust pH is to neutral; 3 times of amount medicinal alcohol depositions are placed 6-12h; The gained throw out is dissolved into 10%~15% concentration, and lyophilize or throw out be through ethanol dehydration, dry handkerchief heparin finished product.
CN2010102871329A 2010-09-16 2010-09-16 Parnaparin production method Active CN101942039B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102871329A CN101942039B (en) 2010-09-16 2010-09-16 Parnaparin production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102871329A CN101942039B (en) 2010-09-16 2010-09-16 Parnaparin production method

Publications (2)

Publication Number Publication Date
CN101942039A CN101942039A (en) 2011-01-12
CN101942039B true CN101942039B (en) 2012-11-28

Family

ID=43434262

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102871329A Active CN101942039B (en) 2010-09-16 2010-09-16 Parnaparin production method

Country Status (1)

Country Link
CN (1) CN101942039B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103421128B (en) * 2013-07-31 2015-08-12 山东辰中生物制药有限公司 A kind of preparation method of that heparin of high-quality low-molecular weight handkerchief
CN104193848B (en) * 2014-08-13 2016-10-05 南京健友生化制药股份有限公司 A kind of remove the method for bacterial endotoxin in heparin sodium
CN104403025B (en) * 2014-12-24 2016-10-05 南京健友生化制药股份有限公司 A kind of liquaemin removes color method
CN105461830A (en) * 2016-01-08 2016-04-06 东营天东制药有限公司 Method for removing copper ions through poly-chelate resin
CN109575156B (en) * 2018-11-05 2021-02-23 上海宝维医药技术有限公司 Purification method of low-molecular heparin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4426289A (en) * 1988-10-05 1990-05-01 Nicola Diferrante Methods for interfering with hiv multiplication and composition for the treatment of aids

Also Published As

Publication number Publication date
CN101942039A (en) 2011-01-12

Similar Documents

Publication Publication Date Title
CN101942039B (en) Parnaparin production method
CN101544999B (en) Method for producing and purifying high purity and low molecular weight sodium heparin
CN101831002B (en) Preparation method of sodium alginate for tissue engineering
KR102591794B1 (en) Method for producing polypentosan sulfate
CN103232558B (en) Preparation method of high-quality low-molecular weight dalteparin sodium
CN104086674A (en) Process for preparing enoxaparin sodium
CN105017360B (en) A kind of preparation method of vitamin B12
TR201910416T4 (en) Process for purification of intended glucose polymers for solutions of peritoneal dialysis.
CN106397630A (en) Method for extracting sodium hyaluronate based on membrane separation technology
CN115160108B (en) Process for preparing inositol and phosphoric acid
CN101492408A (en) Method for separating tryptophane from fermentation liquor
CN106631852A (en) Method for extracting L-ornithine hydrochloride from L-ornithine fermentation broth
CN100372859C (en) Method for preparing medicinal grade cane sugar
CN104448043A (en) Method for producing and purifying enoxaparin sodium
JP2008056599A (en) Process for producing xylose polymer and its reduced product
CN105440163A (en) Method for preparing and purifying enoxaparin sodium
CN102276742A (en) Method for cleanly producing MMW (medium molecular weight) hydroxyethyl starches
CN102276751B (en) Method for extracting glycosaminoglycan from bullacta exarata
CN102584611B (en) Production method for medical grade valine
CN102372788A (en) Mactra veneriformis glycosaminoglycan extraction method
CN101717454B (en) Method for preparing high-purity sodium alginate
CN107827977A (en) A kind of method based on ion-exchange resin purification UTI
CN104262509B (en) The production technique of enzymolysis absorption waste liquid second extraction heparin sodium
KR101938200B1 (en) Novel Method for Recovery of Xylose from Byproducts Generated in Biomass-Pretreatment Processes and Use Thereof
CN102675079B (en) Recovery method of aliphatic calcium alpha-keto acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: DONGYING TIANDONG BIOCHEMICAL INDUSTRY CO., LTD.

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Yang Xiaohong

Inventor after: Zhang Zaizhong

Inventor after: Guo Lin

Inventor after: Li Rong

Inventor after: Wang Chunmei

Inventor after: Liu Wei

Inventor after: Zhang Yanyan

Inventor after: Yu Hexin

Inventor before: Liu Wei

Inventor before: Zhang Yanyan

Inventor before: Yu Hexin

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LIU WEI ZHANG YANYAN YU HEXIN TO: YANG XIAOHONG ZHANG ZAIZHONG GUO LIN LI RONG WANG CHUNMEI LIU WEI ZHANG YANYAN YU HEXIN

TA01 Transfer of patent application right

Effective date of registration: 20110927

Address after: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building

Applicant after: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd.

Co-applicant after: DONGYING TIANDONG BIOCHEMICAL INDUSTRY Co.,Ltd.

Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building

Applicant before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd.

ASS Succession or assignment of patent right

Owner name: DONGYING TIANDONG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: DONGYING TIANDONG BIOCHEMICAL INDUSTRY CO., LTD.

Effective date: 20120914

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Guo Lin

Inventor after: Li Rong

Inventor after: Cui Huifei

Inventor before: Yang Xiaohong

Inventor before: Zhang Zaizhong

Inventor before: Guo Lin

Inventor before: Li Rong

Inventor before: Wang Chunmei

Inventor before: Liu Wei

Inventor before: Zhang Yanyan

Inventor before: Yu Hexin

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: YANG XIAOHONG ZHANG ZAIZHONG GUO LIN LI RONG WANG CHUNMEI LIU WEI ZHANG YANYAN YU HEXIN TO: GUO LIN LI RONG CUI HUIFEI

TA01 Transfer of patent application right

Effective date of registration: 20120914

Address after: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building

Applicant after: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd.

Applicant after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd.

Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building

Applicant before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd.

Applicant before: DONGYING TIANDONG BIOCHEMICAL INDUSTRY Co.,Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: 257000 West of HaoChun Road, Dongying District, Dongying City, Shandong Province

Co-patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd.

Patentee after: Shandong Haike Chemical Co.,Ltd.

Address before: 257000 Shandong District of Dongying city in Dongying Province North Road No. 726 in the building

Co-patentee before: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd.

Patentee before: SHANDONG HI-TECH CHEMICAL GROUP Co.,Ltd.

CP03 Change of name, title or address
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200506

Address after: 257000 No. two, 1236 South Road, Dongying District, Shandong, Dongying

Patentee after: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd.

Address before: 257000 West of HaoChun Road, Dongying District, Dongying City, Shandong Province

Co-patentee before: DONGYING TIANDONG PHARMACEUTICAL Co.,Ltd.

Patentee before: Shandong Haike Chemical Co.,Ltd.